(Q36394348)

13 August 2017

1 reference

title

The endocannabinoid system: a new approach to control cardiovascular disease (English)

1 reference

13 August 2017

endocannabinoid system

0 references

author name string

Christopher P Cannon

series ordinal

1

1 reference

13 August 2017

1 January 2005

1 reference

13 August 2017

1 reference

13 August 2017

7

1 reference

13 August 2017

2-3

1 reference

13 August 2017

17-26

1 reference

The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis

13 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980064-X

7 January 2021

A peripheral mechanism for CB1 cannabinoid receptor-dependent modulation of feeding.

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980064-X

7 January 2021

Endocannabinoids: endogenous cannabinoid receptor ligands with neuromodulatory action.

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980064-X

7 January 2021

Formation and inactivation of endogenous cannabinoid anandamide in central neurons

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980064-X

7 January 2021

The cannabinoid CB1 receptor antagonist SR141716 increases Acrp30 mRNA expression in adipose tissue of obese fa/fa rats and in cultured adipocyte cells

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980064-X

7 January 2021

Molecular aspects of cannabinoid receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980064-X

7 January 2021

Isolation, Structure, and Partial Synthesis of an Active Constituent of Hashish

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980064-X

7 January 2021

Structure of a cannabinoid receptor and functional expression of the cloned cDNA

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980064-X

7 January 2021

Molecular cloning of a human cannabinoid receptor which is also expressed in testis

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980064-X

7 January 2021

Isolation and structure of a brain constituent that binds to the cannabinoid receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980064-X

7 January 2021

Molecular characterization of a peripheral receptor for cannabinoids

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980064-X

7 January 2021

SR141716A, a potent and selective antagonist of the brain cannabinoid receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980064-X

7 January 2021

2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980064-X

7 January 2021

Cannabinoid receptor agonists inhibit glutamatergic synaptic transmission in rat hippocampal cultures.

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980064-X

7 January 2021

Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice.

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980064-X

7 January 2021

Functional CB1 cannabinoid receptors in human vascular endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980064-X

7 January 2021

SR141716, a central cannabinoid (CB(1)) receptor antagonist, blocks the motivational and dopamine-releasing effects of nicotine in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980064-X

7 January 2021

Cannabinoids acting on CB1 receptors decrease contractile performance in human atrial muscle

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980064-X

7 January 2021

Anti-obesity effect of SR141716, a CB1 receptor antagonist, in diet-induced obese mice

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980064-X

7 January 2021

The endocannabinoid system and its therapeutic exploitation

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980064-X

7 January 2021

Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980064-X

7 January 2021

Endocannabinoid signaling in the brain

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980064-X

7 January 2021

The endocannabinoid system and the treatment of obesity

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980064-X

7 January 2021

Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2-arachidonoyl glycerol

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980064-X

7 January 2021

CB1 receptor antagonists for the treatment of nicotine addiction

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980064-X

7 January 2021

Anandamide induces overeating: mediation by central cannabinoid (CB1) receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980064-X

7 January 2021

Dronabinol as a treatment for anorexia associated with weight loss in patients with AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980064-X

7 January 2021

Anandamide administration into the ventromedial hypothalamus stimulates appetite in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980064-X

7 January 2021

In vitro functional evidence of neuronal cannabinoid CB1 receptors in human ileum

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980064-X

7 January 2021

Activation of the peripheral endocannabinoid system in human obesity

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980064-X

7 January 2021

Adipose tissue as an active endocrine organ: recent advances

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980064-X

7 January 2021

The role of the novel adipocyte-derived hormone adiponectin in human disease

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980064-X

7 January 2021

AdipoQ is a novel adipose-specific gene dysregulated in obesity

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980064-X

7 January 2021

Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980064-X

7 January 2021

Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980064-X

7 January 2021

Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980064-X

7 January 2021

Adiponectinemia in visceral obesity: impact on glucose tolerance and plasma lipoprotein and lipid levels in men.

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980064-X

7 January 2021

Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980064-X

7 January 2021

Prognostic impact of body weight and abdominal obesity in women and men with cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980064-X

7 January 2021

Treatment of obesity: need to focus on high risk abdominally obese patients

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980064-X

7 January 2021

Adipose tissue: a mediator of cardiovascular risk

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980064-X

7 January 2021

Trends in waist circumference among U.S. adults

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980064-X

7 January 2021

Abdominal adiposity in U.S. adults: prevalence and trends, 1960-2000.

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980064-X

7 January 2021

Endocannabinoids and the regulation of body fat: the smoke is clearing

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980064-X

7 January 2021

Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980064-X

7 January 2021

10.1016/S1098-3597(05)80064-X

Identifiers

DOI

1 reference

13 August 2017

1 reference

PubMed ID

16473257